CB-5083 drug. Molecular model of a the experimental cancer drug CB-5083. CB-5083 is an inhibitor of valosin-containing protein (VCP) p97, an enzyme involved in protein degradation. CB-5083 is undergoing clinical trials for treatment of tumours. Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (white), nitrogen (dark blue), oxygen (red).
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP16412942
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
1anti-cancerartworkbiochemicalbiochemistrybiologicbiologicalbiologyblackbackgroundcancercancertreatmentcb5083cb-5083cb5083chemicalchemistrychemotherapyclinicaltrialcutoutcutoutscut-outcut-outscutoutcutoutsdigitallygenerateddrugenzymeexperimentalgraphichealthcareillustrationinhibitioninhibitorinvestigationinvestigationalmedicalmedicationmedicinemodelmolecularmoleculenewnooneno-onenobodyoncologyp97pharmaceuticalpharmaceuticspharmacologicalpharmacologyplainbackgroundproteinresearchresearchanddevelopmentspace-fillspace-filledspacefillspacefilledstructuretargetedtesttestingtherapytrialtumourvalosin-containingproteinvcp
15083andanti-cancerartworkbackgroundbackgroundbiochemicalbiochemistrybiologicbiologicalbiologyblackcancercancercbcb-5083cb5083chemicalchemistrychemotherapyclinicalcutcutcut-outcut-outscutoutcutoutsdevelopmentdigitallydrugenzymeexperimentalgeneratedgraphichealthcareillustrationinhibitioninhibitorinvestigationinvestigationalmedicalmedicationmedicinemodelmolecularmoleculenewnono-onenobodyoncologyoneoutoutsp97pharmaceuticalpharmaceuticspharmacologicalpharmacologyplainproteinproteinresearchresearchspace-fillspace-filledspacefillspacefilledstructuretargetedtesttestingtherapytreatmenttrialtrialtumourvalosin-containingvcp